Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Osteosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06438783
What this trial is testing

TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors

Who this might be right for
OsteosarcomaOther Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00027716
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01374672
What this trial is testing

Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic OsteosarcomaOsteoblastic Osteosarcoma+1 more
Children's Oncology Group 20
Early research (Phase 1)Study completedNCT00077454
What this trial is testing

Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood Brain TumorRecurrent Childhood Cerebellar Astrocytoma+9 more
National Cancer Institute (NCI) 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)WithdrawnNCT05042934
What this trial is testing

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

Who this might be right for
Metastatic Ewing SarcomaRecurrent Ewing Sarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598595
What this trial is testing

Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma

Who this might be right for
Recurrent OsteosarcomaRefractory Osteosarcoma
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05590572
What this trial is testing

Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Who this might be right for
Osteosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 148
Testing effectiveness (Phase 2)Ended earlyNCT04129151
What this trial is testing

Palbociclib + Ganitumab In Ewing Sarcoma

Who this might be right for
Ewing SarcomaEwing's Sarcoma Recurrent
Dana-Farber Cancer Institute 10
Not applicableStudy completedNCT03909776
What this trial is testing

Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma

Who this might be right for
Event-free SurvivalOverall SurvivalLocal-recurrence Free Survival+1 more
Peking University People's Hospital 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT03449108
What this trial is testing

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

Who this might be right for
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of Bone+13 more
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT04897880
What this trial is testing

Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT

Who this might be right for
Rhabdoid TumorAtypical Teratoid/Rhabdoid TumorMalignant Rhabdoid Tumor+1 more
Australian & New Zealand Children's Haematology/Oncology Group 25
Testing effectiveness (Phase 2)Study completedNCT00002738
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphomaSarcoma
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00005625
What this trial is testing

Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02357810
What this trial is testing

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Who this might be right for
Adult LiposarcomaMetastatic LiposarcomaMetastatic Osteosarcoma+4 more
Northwestern University 178
Testing effectiveness (Phase 2)Study completedNCT00005033
What this trial is testing

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830667
What this trial is testing

CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat

Who this might be right for
Recurrent Childhood Ewing SarcomaRecurrent Childhood Malignant Solid NeoplasmRecurrent Childhood Rhabdomyosarcoma+9 more
Children's Oncology Group 79
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Next Page